We have previously shown that the known human breast cancer genes BRCA1, BRCA2 and ESR1 are associated with CMT in ESS dogs overlapping with this cohort [25,26], although not as strongly as the risk factors identified in this GWAS study. The gene discussed is BRCA2; the disease is breast carcinoma.